Search Results 1271-1280 of 16772 for monoclonal antibody

1. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

   Participation eligibility · Presence of hepatitis B surface antigen (HBsAg) or anti-hepatitis B core antibody (anti-HBc). · Presence of hepatitis C virus (HCV) ...

2. Study the Variations in the Humoral and Cellular Immune System in Healthy Volunteers - Mayo Clinic

   Subjects that have an antibody incompatibility at the time of their baseline testing or develop an antibody incompatibility. Participating Mayo Clinic ...

3. Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) - Mayo Clinic

   History of severe hypersensitivity reactions to other monoclonal antibodies. Is pregnant or breastfeeding or planning to become pregnant. Has substance ...

4. Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol - Mayo Clinic

   Treatment (within 90 days of screening) with monoclonal antibodies directed towards PCSK9. The above information is not intended to contain all ...

5. Images - Membrane Trafficking in Disease - Mayo Clinic Research

   Dyn2 localizes to the pericentriolar material and centrioles. FR cells were co-stained for endogenous Dyn2 using either the anti-pan-dynamin antibody MC-63 ...

6. Prostate Cancer Clinical Trials - Mayo Clinic Research

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

7. A Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects with Primary Biliary Cirrhosis - Mayo Clinic

   ... antibodies; Documented liver biopsy result consistent with PBC. On a stable and recommended dose of ursodeoxycholic acid for the past twelve months; AP ≥ 1.67 ...

8. Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) - Mayo Clinic

   History of severe hypersensitivity reactions to other monoclonal antibodies which in the opinion of the investigator may pose an increased risk of a serious ...

9. Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas - Mayo Clinic

   Other, prior systemic anti-cancer treatment (chemotherapy or biologic therapy [i.e., monoclonal antibodies]) within 21 days prior to Cycle 1 Day 1. For ...

10. A Study of GC012F, a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma(MM) - Mayo Clinic

    * Have received as part of their previous therapy a PI and IMiD and an antiCD38 antibody. * Have documented evidence of progressive disease by the IMWG ...